human igg1 isotype control (Bio X Cell)
96
Structured Review
Bio X Cell
human igg1 isotype control
Human Igg1 Isotype Control, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 158 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/invivomab+human+igg1+isotype+control/InVivoMAb+human+IgG1+isotype+control/pm42828480-126-34-38
Average 96 stars, based on 158 article reviews
Human Igg1 Isotype Control, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 158 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/invivomab+human+igg1+isotype+control/InVivoMAb+human+IgG1+isotype+control/pm42828480-126-34-38
Average 96 stars, based on 158 article reviews
human igg1 isotype control - by Bioz Stars,
2026-10
96/100 stars
Images
Related Articles
Control:Article Title: CD4+ T cells facilitate replication of primary HIV-1 strains in macrophages and formation of macrophage internal virus-containing compartments. Article Snippet: .. At 4 dpi, MDMs were preincubated with either 10 μM Raltegravir (Sigma) or 10 μM Nevirapine (Merck), or DMSO (Sigma) as a control; 10 μg/mL 3BNC117, PG9, and 10-1074 (NIH HIV Reagent Program); 10 μg/mL InVivoMAb Article Title: Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody Article Snippet: .. Anti–SARS-CoV-2 mAbs (10 μL/well) and InVivoMAb Article Title: CD4+ T cells facilitate replication of primary HIV-1 strains in macrophages and formation of macrophage internal virus-containing compartments Article Snippet: .. At 4 dpi, MDMs were preincubated with either 10 μM Raltegravir (Sigma) or 10 μM Nevirapine (Merck), or DMSO (Sigma) as a control; 10 μg/mL 3BNC117, PG9, and 10-1074 (NIH HIV Reagent Program); 10 μg/mL InVivoMAb Article Title: Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody. Article Snippet: .. Anti–SARS-CoV-2 mAbs (10 μL/well) and InVivoMAb Article Title: DF6215, an α-optimized IL-2-Fc fusion, expands immune effectors and drives robust preclinical anti-tumor activity Article Snippet: .. InVivoMAb Article Title: Disease-specific autoantibody production in the lungs and salivary glands of anti-synthetase syndrome Article Snippet: After washing, the membranes were incubated with an HRP-conjugated anti-mouse or anti-human IgG antibody for 1 h. After extensive washing, signals were visualized using ImmunoStar LD (Fujifilm). .. The following antibodies were used: anti-CD3 (APC/Cy7, UCHT1), anti-CD4 (PE/Cy7, SK3), anti-CD8 (BV510, RPA-T8), anti-CD19 (FITC, HIB19 or BV421, HIB19), anti-sIgD (BV510, IA6–2), anti-CD27 (APC/Cy7, O323), anti-CD38 (PerCP/Cy5.5, HIT2 or FITC, HIT2), anti-CD138 (purified, MI15), anti-CD326 (PE, 9C4), and anti-GFP (purified, 1GFP63) from BioLegend; InVivoMAb Recombinase Polymerase Amplification:Article Title: CD4+ T cells facilitate replication of primary HIV-1 strains in macrophages and formation of macrophage internal virus-containing compartments. Article Snippet: .. At 4 dpi, MDMs were preincubated with either 10 μM Raltegravir (Sigma) or 10 μM Nevirapine (Merck), or DMSO (Sigma) as a control; 10 μg/mL 3BNC117, PG9, and 10-1074 (NIH HIV Reagent Program); 10 μg/mL InVivoMAb Article Title: CD4+ T cells facilitate replication of primary HIV-1 strains in macrophages and formation of macrophage internal virus-containing compartments Article Snippet: .. At 4 dpi, MDMs were preincubated with either 10 μM Raltegravir (Sigma) or 10 μM Nevirapine (Merck), or DMSO (Sigma) as a control; 10 μg/mL 3BNC117, PG9, and 10-1074 (NIH HIV Reagent Program); 10 μg/mL InVivoMAb Article Title: Disease-specific autoantibody production in the lungs and salivary glands of anti-synthetase syndrome Article Snippet: After washing, the membranes were incubated with an HRP-conjugated anti-mouse or anti-human IgG antibody for 1 h. After extensive washing, signals were visualized using ImmunoStar LD (Fujifilm). .. The following antibodies were used: anti-CD3 (APC/Cy7, UCHT1), anti-CD4 (PE/Cy7, SK3), anti-CD8 (BV510, RPA-T8), anti-CD19 (FITC, HIB19 or BV421, HIB19), anti-sIgD (BV510, IA6–2), anti-CD27 (APC/Cy7, O323), anti-CD38 (PerCP/Cy5.5, HIT2 or FITC, HIT2), anti-CD138 (purified, MI15), anti-CD326 (PE, 9C4), and anti-GFP (purified, 1GFP63) from BioLegend; InVivoMAb Derivative Assay:Article Title: CD4+ T cells facilitate replication of primary HIV-1 strains in macrophages and formation of macrophage internal virus-containing compartments. Article Snippet: .. At 4 dpi, MDMs were preincubated with either 10 μM Raltegravir (Sigma) or 10 μM Nevirapine (Merck), or DMSO (Sigma) as a control; 10 μg/mL 3BNC117, PG9, and 10-1074 (NIH HIV Reagent Program); 10 μg/mL InVivoMAb Article Title: CD4+ T cells facilitate replication of primary HIV-1 strains in macrophages and formation of macrophage internal virus-containing compartments Article Snippet: .. At 4 dpi, MDMs were preincubated with either 10 μM Raltegravir (Sigma) or 10 μM Nevirapine (Merck), or DMSO (Sigma) as a control; 10 μg/mL 3BNC117, PG9, and 10-1074 (NIH HIV Reagent Program); 10 μg/mL InVivoMAb Purification:Article Title: Disease-specific autoantibody production in the lungs and salivary glands of anti-synthetase syndrome Article Snippet: After washing, the membranes were incubated with an HRP-conjugated anti-mouse or anti-human IgG antibody for 1 h. After extensive washing, signals were visualized using ImmunoStar LD (Fujifilm). .. The following antibodies were used: anti-CD3 (APC/Cy7, UCHT1), anti-CD4 (PE/Cy7, SK3), anti-CD8 (BV510, RPA-T8), anti-CD19 (FITC, HIB19 or BV421, HIB19), anti-sIgD (BV510, IA6–2), anti-CD27 (APC/Cy7, O323), anti-CD38 (PerCP/Cy5.5, HIT2 or FITC, HIT2), anti-CD138 (purified, MI15), anti-CD326 (PE, 9C4), and anti-GFP (purified, 1GFP63) from BioLegend; InVivoMAb |